Private Advisor Group, LLC

Position in IBRX — ImmunityBio, Inc.

CIK 1567755 MORRISTOWN, NJ

Position in IBRX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$12,644,424

+$12,325,498 QoQ

Shares Held

1,648,556

+923.5% QoQ

Ownership

0.157%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Private Advisor Group, LLC holds $54,215,312 across 44 Biotechnology names. IBRX ranks #2 (23.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	17,315	$13,378,261
2	IBRX	ImmunityBio, Inc. This page	1,648,556	$12,644,424
3	CRSP	CRISPR Therapeutics AG	106,662	$5,073,911
4	VRTX	Vertex Pharmaceuticals Inc / Ma	8,433	$3,765,671
5	CRMD	CorMedix Inc.	504,668	$3,426,695
6	TLX	Telix Pharmaceuticals Ltd	174,415	$1,669,151
7	AVXL	Anavex Life Sciences Corp.	499,700	$1,534,079
8	CDXS	Codexis, Inc.	847,001	$1,380,611

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,644,424	1,648,556	+923.5%	Shares	Sole	2026-04-27
2025-12-31	$318,926	161,074	+1153.3%	Shares	Sole	2026-02-17
2025-09-30	$31,615	12,852	-1.6%	Shares	Sole	2025-11-13
2025-06-30	$34,465	13,055	+1.6%	Shares	Sole	2025-08-11
2025-03-31	$38,684	12,852	-4.4%	Shares	Sole	2025-05-05
2024-12-31	$34,432	13,450	-75.4%	Shares	Sole	2025-02-03
2024-09-30	$203,733	54,767	-37.0%	Shares	Sole	2024-10-22
2024-06-30	$549,252	86,907	+727.7%	Shares	Sole	2024-08-05
2024-03-31	$56,385	10,500	0.0%	Shares	Sole	2024-04-30
2023-12-31	$52,710	10,500	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.